A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/19 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2698128
The invention relates to the use of G-CSF for the treatment of cerebral stroke, in particular cerebral stroke having an initial large infarct volume. The administration of G-CSF in a total dose of 30 to 180 µg per kg of body weight over a treatment time of approximately 3 days is suitable for the treatment of stroke. The treatment according to the invention using a total dose of 80 to 150 µg per kg of body weight is preferred.
L'invention concerne l'utilisation de G-CSF pour le traitement de l'apoplexie cérébrale, en particulier, de l'apoplexie cérébrale avec volume d'infarctus initialement élevé. L'administration de G-CSF à une dose totale de 30 à 180 µg par kg de poids du corps, sur une période de traitement d'environ 3 jours, est appropriée pour le traitement de l'apoplexie cérébrale. De préférence, le traitement selon l'invention s'effectue à une dose totale de 80 à 150 µg par kg de poids du corps.
Koch Winfried
Laage Rico
Schneider Armin
Vogt Gerhard
Bcf Llp
Sygnis Bioscience Gmbh & Co. Kg
LandOfFree
Use of g-csf for the treatment of stroke does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of g-csf for the treatment of stroke, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of g-csf for the treatment of stroke will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486214